0001144204-13-065673.txt : 20131205 0001144204-13-065673.hdr.sgml : 20131205 20131204205743 ACCESSION NUMBER: 0001144204-13-065673 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20131205 DATE AS OF CHANGE: 20131204 EFFECTIVENESS DATE: 20131205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CAPRICOR THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001133869 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-207421 FILM NUMBER: 131258575 BUSINESS ADDRESS: STREET 1: 8840 WILSHIRE BLVD STREET 2: 2ND FLOOR CITY: BEVERLY HILLS STATE: CA ZIP: 90211 BUSINESS PHONE: (310) 358-3200 MAIL ADDRESS: STREET 1: 8840 WILSHIRE BLVD STREET 2: 2ND FLOOR CITY: BEVERLY HILLS STATE: CA ZIP: 90211 FORMER COMPANY: FORMER CONFORMED NAME: Nile Therapeutics, Inc. DATE OF NAME CHANGE: 20070920 FORMER COMPANY: FORMER CONFORMED NAME: SMI PRODUCTS INC DATE OF NAME CHANGE: 20010206 D 1 primary_doc.xml X0707 D LIVE 0001133869 CAPRICOR THERAPEUTICS, INC. 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA CALIFORNIA 90211 (310) 358-3200 DELAWARE None Nile Therapeutics, Inc. SMI PRODUCTS INC Corporation true Linda Marban c/o Capricor Therapeutics, Inc. 8840 Wilshire Blvd., 2nd Floor Beverly Hills CA CALIFORNIA 90211 Executive Officer Director Anthony Davies c/o Capricor Therapeutics, Inc. 8840 Wilshire Blvd., 2nd Floor Beverly Hills CA CALIFORNIA 90211 Executive Officer Karen Krasney c/o Capricor Therapeutics, Inc. 8840 Wilshire Blvd., 2nd Floor Beverly Hills CA CALIFORNIA 90211 Executive Officer Anthony Bergmann c/o Capricor Therapeutics, Inc. 8840 Wilshire Blvd., 2nd Floor Beverly Hills CA CALIFORNIA 90211 Executive Officer Rachel Smith c/o Capricor Therapeutics, Inc. 8840 Wilshire Blvd., 2nd Floor Beverly Hills CA CALIFORNIA 90211 Executive Officer Andrew Hamer c/o Capricor Therapeutics, Inc. 8840 Wilshire Blvd., 2nd Floor Beverly Hills CA CALIFORNIA 90211 Executive Officer Frank Litvack c/o Capricor Therapeutics, Inc. 8840 Wilshire Blvd., 2nd Floor Beverly Hills CA CALIFORNIA 90211 Director Earl Collier, Jr. c/o Capricor Therapeutics, Inc. 8840 Wilshire Blvd., 2nd Floor Beverly Hills CA CALIFORNIA 90211 Director George Dunbar c/o Capricor Therapeutics, Inc. 8840 Wilshire Blvd., 2nd Floor Beverly Hills CA CALIFORNIA 90211 Director David Musket c/o Capricor Therapeutics, Inc. 8840 Wilshire Blvd., 2nd Floor Beverly Hills CA CALIFORNIA 90211 Director Louis Grasmick c/o Capricor Therapeutics, Inc. 8840 Wilshire Blvd., 2nd Floor Beverly Hills CA CALIFORNIA 90211 Director Louis Manzo c/o Capricor Therapeutics, Inc. 8840 Wilshire Blvd., 2nd Floor Beverly Hills CA CALIFORNIA 90211 Director Joshua Kazam c/o Capricor Therapeutics, Inc. 8840 Wilshire Blvd., 2nd Floor Beverly Hills CA CALIFORNIA 90211 Director Gregory Schafer c/o Capricor Therapeutics, Inc. 8840 Wilshire Blvd., 2nd Floor Beverly Hills CA CALIFORNIA 90211 Director Biotechnology Decline to Disclose 06b false 2013-11-20 false true true Common stock issued in connection with the merger of a wholly-owned subsidiary of Nile Therapeutics, Inc. with and into Capricor, Inc. 0 26289973 26289973 0 Total shares issued pursuant to the terms of the merger agreement, multiplied by the price of the common stock ($2.50 per share after the reverse stock split) on the date of closing (11/20/2013). true 7 34 0 0 Not applicable. 0 false CAPRICOR THERAPEUTICS, INC. /s/ Linda Marban Linda Marban Chief Executive Officer 2013-12-04